Psychopharmacological treatment in PTSD: a critical review (Q34977242)

5 August 2017

1 reference

title

Psychopharmacological treatment in PTSD: a critical review (English)

1 reference

post-traumatic stress disorder

5 August 2017

main subject

0 references

Israel Liberzon

2

0 references

author name string

Ronald C Albucher

series ordinal

1

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Journal of Psychiatric Research

5 August 2017

published in

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

355-367

1 reference

Rodent anxiety and kindling of the central amygdala and nucleus basalis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Amygdala kindling and anxiety in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Valproate as an Alternative in Post-Traumatic Stress Disorder: A Case Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Treatment of flashbacks with naltrexone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Treatment of post-traumatic stress disorder with imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Bupropion treatment in veterans with posttraumatic stress disorder: an open study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A pilot study of mirtazapine in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Kindling in the hypothalamus and transfer to the ipsilateral amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A Pilot Study of Phenelzine in the Treatment of Post-traumatic Stress Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluvoxamine in civilians with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluvoxamine treatment for chronic PTSD: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Monoamine oxidase inhibitors in posttraumatic stress disorder. Promise and problems in Indochinese survivors of trauma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Use of thioridazine in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

The use of anticonvulsants in posttraumatic stress disorder: case study and overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Lithium for irritability in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A permanent change in brain function resulting from daily electrical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Clozapine treatment for a veteran with comorbid psychosis and PTSD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Clonidine for posttraumatic stress disorder in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Nefazodone in post-traumatic stress disorder: results from six open-label trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Treatment of traumatic war neurosis with phenelzine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Guanfacine for PTSD nightmares

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Inositol treatment of post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Low dose lithium carbonate in the treatment of post traumatic stress disorder: brief communication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Risperidone as an adjunct therapy for post-traumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Impulsivity, aggression, and serotonin: a molecular psychobiological perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Preliminary study of carbamazepine in post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

7 January 2021

Carbamazepine for PTSD

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Vigabatrin and posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluoxetine and fluvoxamine in PTSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluoxetine versus placebo in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

The neurobiology of stress: from serendipity to clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Auditory hallucinations in combat-related chronic posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

An open trial of moclobemide in the treatment of post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Neurobiology of posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Increased anxiety of mice lacking the serotonin1A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Serotonin receptor 1A knockout: an animal model of anxiety-related disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Sertraline in the treatment of rape victims with posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

An open trial of citalopram in adolescents with post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Open trial of citalopram in adults with post-traumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Use of benzodiazepines in anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Alprazolam reduces response to loud tones in panic disorder but not in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluoxetine reduces explosiveness and elevates mood of vietnam combat vets with PTSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

A controlled trial of phenelzine in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Noradrenergic and serotonergic function in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Low platelet-poor plasma concentrations of serotonin in patients with combat-related posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Fluvoxamine reduces physiologic reactivity to trauma scripts in posttraumatic stress disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Chemotherapy of traumatic war stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Kindling: separate vs. shared mechanisms in affective disorders and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

Open trial of nefazodone for combat-related posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

7 January 2021

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

7 January 2021

Nefazodone in patients with treatment-refractory posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

7 January 2021

Characterization of the defensive nature of kindling-induced emotionality

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900058-4

7 January 2021

10.1016/S0022-3956(02)00058-4

Identifiers

DOI

1 reference

5 August 2017

1 reference